​
Login / Signup
Masao Omata
ORCID
Publication Activity (10 Years)
Years Active: 2022-2024
Publications (10 Years): 8
Top Topics
Fine Needle Aspiration
Endometrial Cancer
Dna Repair
High Grade
Top Venues
Journal of gynecologic oncology
Cancer cytopathology
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Takahiro Nozaki
,
Ikuko Sakamoto
,
Keiko Kagami
,
Kenji Amemiya
,
Yosuke Hirotsu
,
Hitoshi Mochizuki
,
Masao Omata
Clinical and molecular biomarkers predicting response to PARP inhibitors in ovarian cancer.
Journal of gynecologic oncology
35 (4) (2024)
Takahiro Nozaki
,
Ikuko Sakamoto
,
Keiko Kagami
,
Kenji Amemiya
,
Yosuke Hirotsu
,
Hitoshi Mochizuki
,
Masao Omata
Clinical and molecular biomarkers predicting response to PARP inhibitors in ovarian cancer.
Journal of gynecologic oncology
(2024)
Takahiro Nozaki
,
Ikuko Sakamoto
,
Keiko Kagami
,
Kenji Amemiya
,
Yosuke Hirotsu
,
Hitoshi Mochizuki
,
Masao Omata
Clinical and molecular biomarkers predicting response to PARP inhibitors in ovarian cancer.
Journal of gynecologic oncology
35 (4) (2024)
Takahiro Nozaki
,
Ikuko Sakamoto
,
Keiko Kagami
,
Kenji Amemiya
,
Yosuke Hirotsu
,
Hitoshi Mochizuki
,
Masao Omata
Clinical and molecular biomarkers predicting response to PARP inhibitors in ovarian cancer.
Journal of gynecologic oncology
35 (4) (2024)
Takahiro Nozaki
,
Ikuko Sakamoto
,
Keiko Kagami
,
Kenji Amemiya
,
Yosuke Hirotsu
,
Hitoshi Mochizuki
,
Masao Omata
Clinical and molecular biomarkers predicting response to PARP inhibitors in ovarian cancer.
Journal of gynecologic oncology
35 (4) (2024)
Takahiro Nozaki
,
Ikuko Sakamoto
,
Keiko Kagami
,
Kenji Amemiya
,
Yosuke Hirotsu
,
Hitoshi Mochizuki
,
Masao Omata
Clinical and molecular biomarkers predicting response to PARP inhibitors in ovarian cancer.
Journal of gynecologic oncology
35 (4) (2024)
Takahiro Nozaki
,
Ikuko Sakamoto
,
Keiko Kagami
,
Kenji Amemiya
,
Yosuke Hirotsu
,
Hitoshi Mochizuki
,
Masao Omata
Molecular analysis of ascitic fluid cytology reflects genetic changes of malignancies of the ovary equivalent to surgically resected specimens.
Cancer cytopathology
130 (8) (2022)
Ikuko Sakamoto
,
Yosuke Hirotsu
,
Kenji Amemiya
,
Takahiro Nozaki
,
Hitoshi Mochizuki
,
Masao Omata
Elucidation of genomic origin of synchronous endometrial and ovarian cancer (SEO) by genomic and microsatellite analysis.
Journal of gynecologic oncology
(2022)